Page last updated: 2024-11-12

vismione b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vismione B: from Cratoxylum sumatranum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Cratoxylumgenus[no description available]Hypericaceae[no description available]

Cross-References

ID SourceID
PubMed CID10247551
CHEMBL ID486405
SCHEMBL ID5024985
MeSH IDM0425180

Synonyms (4)

Synonym
CHEMBL486405
vismione b
SCHEMBL5024985
9,12-dihydroxy-5-methoxy-2,2,9-trimethyl-8,10-dihydronaphtho[6,7-h]chromen-11-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID332874Cytotoxicity against mouse doxorubicin-resistant P388 cells after 3 days
AID332300Cytotoxicity against human KB cells by MTT assay2002Journal of natural products, Mar, Volume: 65, Issue:3
Cytotoxic prenylated xanthones and the unusual compounds anthraquinobenzophenones from Cratoxylum sumatranum.
AID332873Cytotoxicity against mouse doxorubicin-sensitive P388 cells after 3 days
AID356018Cytotoxicity against human SF268 cells2003Journal of natural products, Jun, Volume: 66, Issue:6
Bioactive constituents from three Vismia species.
AID356017Cytotoxicity against human H460 cells2003Journal of natural products, Jun, Volume: 66, Issue:6
Bioactive constituents from three Vismia species.
AID356016Cytotoxicity against human MCF7 cells2003Journal of natural products, Jun, Volume: 66, Issue:6
Bioactive constituents from three Vismia species.
AID332886Cytotoxicity against human 9KB cells after 3 days
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.72 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]